Redmile Group’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,061,295
Closed -$41.1M 82
2023
Q1
$41.1M Sell
1,061,295
-359,322
-25% -$11.6M 1.78% 19
2022
Q4
$30.6M Buy
1,420,617
+359,322
+34% +$7.52M 1.25% 25
2022
Q3
$26M Sell
1,061,295
-322,324
-23% -$8.53M 1.01% 32
2022
Q2
$22.7M Buy
1,383,619
+180,000
+15% +$3.5M 0.87% 34
2022
Q1
$32.4M Hold
1,203,619
1.01% 27
2021
Q4
$39.9M Sell
1,203,619
-674,901
-36% -$25.5M 0.91% 33
2021
Q3
$79.9M Sell
1,878,520
-424,133
-18% -$22.8M 1.39% 26
2021
Q2
$135M Sell
2,302,653
-627,758
-21% -$37.4M 2% 15
2021
Q1
$159M Buy
2,930,411
+4,700
+0.2% +$261K 2.24% 12
2020
Q4
$179M Buy
2,925,711
+273,300
+10% +$14.3M 2.17% 11
2020
Q3
$142M Buy
+2,652,411
New +$119M 2.6% 10

Other funds holding OSH

Redmile Group's OSH Position: Q2 2023 in Review

Redmile Group sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 1,061,295 shares — an estimated $41.1M sold.

Redmile Group first reported a position in OSH in Q3 2020 and held it in 11 quarters. The position peaked at $179M in Q4 2020. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • Redmile Group reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Redmile Group sold 1,061,295 Oak Street Health, Inc. shares in Q2 2023, an estimated $41.1M.
  • Redmile Group first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 11 quarters.
  • Redmile Group's Oak Street Health, Inc. position peaked at $179M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Redmile Group's 13F filing for Q2 2023, filed 14 Aug 2023.